Respiratory Devices Market

Respiratory Devices Market (Product Type: Therapeutic Devices and Diagnostic & Monitoring Devices) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Respiratory Devices Market Outlook 2031

  • The global industry was valued at US$ 22.2 Bn in 2022
  • It is estimated to grow at a CAGR of 6.1% from 2023 to 2031 and reach US$ 37.7 Bn by the end of 2031

Analyst Viewpoint

High efficacy of respiratory devices in the treatment of COPD is a prominent driver of the global respiratory devices market size. Inhalers and nebulizers are two primary respiratory devices that are utilized in the care of patients suffering from COPD. While other treatment modalities are available for the disease, the usage of respiratory devices has shown particularly promising results in patient prognosis. Rapid rate of technological advancements is also fueling market expansion.

Key players operating in the global market are focusing on scaling up their production capacities. They are also investigating the use of novel materials and delivery methods to reduce the price of devices. Favorable government regulations to fast-track the production of these devices and broaden their range of application are expected to provide novel respiratory devices market opportunities to companies operating in the global landscape.

Respiratory Devices Market

Market Introduction

The quality of respiratory devices has improved significantly in recent years. These modern instruments are used for a wide range of respiratory disorders. The emphasis on respiratory equipment and quality of life has increased substantially, particularly after the COVID-19 Pandemic. However, there are still many unknowns for patients.

It might be challenging to determine which device is ideal for each individual's medical condition. Someone suffering from chronic lung illness may require different breathing apparatus than someone suffering from other respiratory ailments.

Respiratory aids are devices designed to help patients requiring assistance with breathing and treatment to prevent disuse atrophy of abdominal wall muscles. Individuals who require breathing assistance tools such as oxygen therapy tools are often prescribed respiratory masks. These devices are utilized for a wide range of patients in the hospital, from newborns with underdeveloped lungs to the elderly with persistent respiratory difficulties.

High Efficacy in Treatment of COPD Augmenting Respiratory Devices Market Growth

COPD, or chronic obstructive pulmonary disease, is the biggest cause of mortality in the world today. The condition is distinguished by chronic respiratory symptoms and restricted airflow. It is a sickness that may be treated and avoided.

The burden of COPD is expected to rise even more in the near future due to the growth in population and increase in COPD risk factors such as tobacco usage, dust, chemicals, burning biomass fuel, and surging air pollution.

COPD care typically involves the usage of different devices to improve lung function, reduce side effects produced by COPD medication, and improve the patient's overall personal satisfaction. Inhalers are an important tool in COPD therapy, since they deliver medications directly to the inhalation paths.

Metered-portion inhalers (MDIs), dry powder inhalers (DPIs), and soft mist inhalers (SMIs) are some of the inhalers that have undergone continuous advancements in medication transportation proficiency, usability, and adaptability.

Some inhalers now feature concealed sensors that monitor consumption and provide feedback to consumers and medical care providers. Nebulizer, which transforms fluid medications into a fine fog, makes it easier for patients to breathe in the medicines.

Recent improvements in nebulizers for asthma management in children have focused on shortening treatment duration. These factors are expected to influence rapid development in the respiratory devices market.

Rapid Rate of Technological Advancements Bolstering Market Progress

Introduction of technologically advanced respiratory devices, such as sensors and pulse dose meters, that offer quality patient prognosis is expected to promote respiratory devices market development. These devices allow one to control the flow of oxygen.

Adoption of sophisticated respiratory breathing devices is becoming increasingly popular across the globe. Benefits provided by these devices include a quicker reaction rate, more efficient dosing, regulated flow, and increased dependability and durability.

Medical professionals and clinicians favor respiratory therapy devices for the treatment of a wide range of respiratory illnesses. In the case of emergency and chronic patient care, these devices enable instant medical intervention.

Rise in knowledge about the usage of respiratory devices, their advantages, and recent breakthroughs in the sector are projected to drive the respiratory devices industry in the near future. The usage of Portable Oxygen Concentrators for travel (POC) in a variety of applications, including emergency medicine, is emerging as a new opportunity for the global respiratory devices industry growth.

Regional Outlook

According to the latest respiratory devices market research, North America accounted for the largest share of the global landscape in 2022. The region's prominence can be ascribed to the existence of well-developed healthcare infrastructure, rise in population awareness, and continual technological improvements.

Increase in patient pool that is prone to respiratory disorders is also likely to boost North America’s respiratory devices market share during the projection period. Growth in prevalence of COPD is augmenting the demand for respiratory equipment, thus contributing to a positive market forecast during the forecast period.

Analysis of Key Players

As per respiratory devices market analysis, firms engaged in the manufacture of respiratory devices are launching products based on clinical urgency for higher mobility support for the senior population and rising need for portable technology. A diverse product selection is expected to help players establish widespread client base.

Some of the key players operating in the respiratory devices market are ResMed, Koninklijke Philips N.V., Vyaire Medical, Inc. (Becton, Dickinson and Company), Smiths Medical (part of Smiths Group plc), Fisher & Paykel Healthcare Limited, Drägerwerk AG & Co. KGaA, GE Healthcare (part of General Electric Company), Getinge AB, Medtronic plc, and Chart Industries.

Each of these players has been profiled in the respiratory devices market report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Key Developments

  • In July 2023, ResMed, a leading medical device company, acquired Somnoware, a U.S.-based provider of sleep and respiratory care diagnostics software, for an undisclosed sum. The company aims to integrate Somnoware’s products and services into its brand and solution portfolio through this move.
  • In October 2022, Medtronic announced a spinoff move to separate its combined patient monitoring and respiratory interventions businesses from the rest of the company’s medical surgical portfolio. The company sees the spinoff, dubbed NewCo, as an opportunity to better position both entities and create value.

Respiratory Devices Market Snapshot

Attribute Detail
Market Value in 2022 (Base Year) US$ 22.2 Bn
Market Forecast Value in 2031 US$ 37.7 Bn
Growth Rate (CAGR) 6.1%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value
Market Analysis Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis.
Competition Landscape
  • Prominent Players – Competition Dashboard and Revenue Share Analysis, 2023
  • Company Profiles (Details – Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
Format Electronic (PDF) + Excel
Market Segmentation
  • Product Type
    • Therapeutic Devices
    • Diagnostic & Monitoring Devices
  • Therapeutic Devices
    • Drug Delivery Devices
      • Nebulizers
      • Inhalers
    • Mechanical Ventilators
      • Invasive
      • Non-invasive
    • Continuous Positive Airway Pressure
      • Devices
      • Disposables
    • Resuscitators
      • Reusable
      • Disposables
    • Humidifiers
    • Airway Clearance Devices
    • Oxygen Concentrators
    • Consumables & Disposables
    • Others
  • Diagnostic & Monitoring Devices
    • Pulse Oximeters
    • Capnographs
    • Spirometers
    • Polysomnographs
    • Peak Flow Meters
    • Gas Analyzers
    • Others
  • Application
    • Chronic Obstructive Pulmonary Disease
    • Asthma
    • Obstructive Sleep Apnea
    • Respiratory Distress Syndrome
    • Cystic Fibrosis
    • Pneumonia
Regions Covered
  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC
  • South Africa
Companies Profiled
  • ResMed
  • Koninklijke Philips N.V.
  • Vyaire Medical, Inc. (Becton, Dickinson and Company)
  • Smiths Medical (part of Smiths Group plc)
  • Fisher & Paykel Healthcare Limited
  • Drägerwerk AG & Co. KGaA
  • GE Healthcare (part of General Electric Company)
  • Getinge AB
  • Medtronic plc
  • Chart Industries
Customization Scope Available upon Request
Pricing Available upon Request

Frequently Asked Questions

How big was the global respiratory devices market in 2022?

It was valued at US$ 22.2 Bn in 2022

How is the respiratory devices business expected to grow by 2031?

It is likely to grow at a CAGR of 6.1% from 2023 to 2031

What are the key factors driving the demand for respiratory devices?

High efficacy of respiratory devices in the treatment of COPD and rapid rate of technological advancements

Which was the major region in the global respiratory devices landscape in 2022?

North America was the leading region in 2022

Who are the key respiratory device manufacturers?

ResMed, Koninklijke Philips N.V, and Vyaire Medical, Inc. (Becton, Dickinson and Company), Smiths Medical (part of Smiths Group plc), Fisher & Paykel Healthcare Limited, Drägerwerk AG & Co. KGaA, GE Healthcare (part of General Electric Company), Getinge AB, Medtronic plc, and Chart Industries

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Respiratory Devices Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Respiratory Devices Market Analysis and Forecast, 2017-2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Respiratory Devices Market Analysis and Forecast, by Product Type

        6.1. Introduction and Definitions

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product Type, 2017–2031

            6.3.1. Therapeutic Devices

            6.3.2. Diagnostic & Monitoring Devices

        6.4. Market Attractiveness, by Product Type

    7. Global Respiratory Devices Market Analysis and Forecast, by Therapeutic Devices

        7.1. Introduction and Definitions

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Therapeutic Devices, 2017–2031

            7.3.1. Drug Delivery Devices

                7.3.1.1. Nebulizers

                7.3.1.2. Inhalers

            7.3.2. Mechanical Ventilators

                7.3.2.1. Invasive

                7.3.2.2. Non-invasive

            7.3.3. Continuous Positive Airway Pressure

                7.3.3.1. Devices

                7.3.3.2. Disposables

            7.3.4. Resuscitators

                7.3.4.1. Reusable

                7.3.4.2. Disposables

            7.3.5. Humidifiers

            7.3.6. Airway Clearance Devices

            7.3.7. Oxygen Concentrators

            7.3.8. Consumables & Disposables

            7.3.9. Others

            7.3.10. 7.4 Market Attractiveness, by Therapeutic Devices

    8. Global Respiratory Devices Market Analysis and Forecast, by Diagnostic & Monitoring Devices

        8.1. Introduction and Definitions

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017–2031

            8.3.1. Pulse Oximeters

            8.3.2. Capnographs

            8.3.3. Spirometers

            8.3.4. Polysomnographs

            8.3.5. Peak Flow Meters

            8.3.6. Gas Analyzers

            8.3.7. Others

        8.4. Market Attractiveness, by Diagnostic & Monitoring Devices

    9. Global Respiratory Devices Market Analysis and Forecast, by Application

        9.1. Introduction and Definitions

        9.2. Key Findings/Developments

        9.3. Market Value Forecast, by Application, 2017–2031

            9.3.1. Chronic Obstructive Pulmonary Disease

            9.3.2. Asthma

            9.3.3. Obstructive Sleep Apnea

            9.3.4. Respiratory Distress Syndrome

            9.3.5. Cystic Fibrosis

            9.3.6. Pneumonia

        9.4. Market Attractiveness, by Application

    10. Global Respiratory Devices Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region, 2017–2031

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness, by Region

    11. North America Respiratory Devices Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product Type, 2017–2031

            11.2.1. Therapeutic Devices

            11.2.2. Diagnostic & Monitoring Devices

        11.3. Market Attractiveness, by Product Type

        11.4. Market Value Forecast, by Therapeutic Devices, 2017–2031

            11.4.1. Drug Delivery Devices

                11.4.1.1. Nebulizers

                11.4.1.2. Inhalers

            11.4.2. Mechanical Ventilators

                11.4.2.1. Invasive

                11.4.2.2. Non-invasive

            11.4.3. Continuous Positive Airway Pressure

                11.4.3.1. Devices

                11.4.3.2. Disposables

            11.4.4. Resuscitators

                11.4.4.1. Reusable

                11.4.4.2. Disposables

            11.4.5. Humidifiers

            11.4.6. Airway Clearance Devices

            11.4.7. Oxygen Concentrators

            11.4.8. Consumables & Disposables

            11.4.9. Others

        11.5. Market Attractiveness, by Therapeutic Devices

        11.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017–2031

            11.6.1. Pulse Oximeters

            11.6.2. Capnographs

            11.6.3. Spirometers

            11.6.4. Polysomnographs

            11.6.5. Peak Flow Meters

            11.6.6. Gas Analyzers

            11.6.7. Others

        11.7. Market Attractiveness, by Diagnostic & Monitoring Devices

        11.8. Market Value Forecast, by Application, 2017–2031

            11.8.1. Chronic Obstructive Pulmonary Disease

            11.8.2. Asthma

            11.8.3. Obstructive Sleep Apnea

            11.8.4. Respiratory Distress Syndrome

            11.8.5. Cystic Fibrosis

            11.8.6. Pneumonia

        11.9. Market Attractiveness, by Application

        11.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.10.1. U.S.

            11.10.2. Canada

        11.11. Market Attractiveness Analysis

            11.11.1. By Product Type

            11.11.2. By Therapeutic Devices

            11.11.3. By Diagnostic & Monitoring Devices

            11.11.4. By Application

            11.11.5. By Country

    12. Europe Respiratory Devices Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product Type, 2017–2031

            12.2.1. Therapeutic Devices

            12.2.2. Diagnostic & Monitoring Devices

        12.3. Market Attractiveness, by Product Type

        12.4. Market Value Forecast, by Therapeutic Devices, 2017–2031

            12.4.1. Drug Delivery Devices

                12.4.1.1. Nebulizers

                12.4.1.2. Inhalers

            12.4.2. Mechanical Ventilators

                12.4.2.1. Invasive

                12.4.2.2. Non-invasive

            12.4.3. Continuous Positive Airway Pressure

                12.4.3.1. Devices

                12.4.3.2. Disposables

            12.4.4. Resuscitators

                12.4.4.1. Reusable

                12.4.4.2. Disposables

            12.4.5. Humidifiers

            12.4.6. Airway Clearance Devices

            12.4.7. Oxygen Concentrators

            12.4.8. Consumables & Disposables

            12.4.9. Others

        12.5. Market Attractiveness, by Therapeutic Devices

        12.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017–2031

            12.6.1. Pulse Oximeters

            12.6.2. Capnographs

            12.6.3. Spirometers

            12.6.4. Polysomnographs

            12.6.5. Peak Flow Meters

            12.6.6. Gas Analyzers

            12.6.7. Others

        12.7. Market Attractiveness, by Diagnostic & Monitoring Devices

        12.8. Market Value Forecast, by Application, 2017–2031

            12.8.1. Chronic Obstructive Pulmonary Disease

            12.8.2. Asthma

            12.8.3. Obstructive Sleep Apnea

            12.8.4. Respiratory Distress Syndrome

            12.8.5. Cystic Fibrosis

            12.8.6. Pneumonia

        12.9. Market Attractiveness, by Application

        12.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.10.1. Germany

            12.10.2. U.K.

            12.10.3. France

            12.10.4. Italy

            12.10.5. Spain

            12.10.6. Rest of Europe

        12.11. Market Attractiveness Analysis

            12.11.1. By Product Type

            12.11.2. By Therapeutic Devices

            12.11.3. By Diagnostic & Monitoring Devices

            12.11.4. By Application

            12.11.5. By Country/Sub-region

    13. Asia Pacific Respiratory Devices Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product Type, 2017–2031

            13.2.1. Therapeutic Devices

            13.2.2. Diagnostic & Monitoring Devices

        13.3. Market Attractiveness, by Product Type

        13.4. Market Value Forecast, by Therapeutic Devices, 2017–2031

            13.4.1. Drug Delivery Devices

                13.4.1.1. Nebulizers

                13.4.1.2. Inhalers

            13.4.2. Mechanical Ventilators

                13.4.2.1. Invasive

                13.4.2.2. Non-invasive

            13.4.3. Continuous Positive Airway Pressure

                13.4.3.1. Devices

                13.4.3.2. Disposables

            13.4.4. Resuscitators

                13.4.4.1. Reusable

                13.4.4.2. Disposables

            13.4.5. Humidifiers

            13.4.6. Airway Clearance Devices

            13.4.7. Oxygen Concentrators

            13.4.8. Consumables & Disposables

            13.4.9. Others

        13.5. Market Attractiveness, by Therapeutic Devices

        13.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017–2031

            13.6.1. Pulse Oximeters

            13.6.2. Capnographs

            13.6.3. Spirometers

            13.6.4. Polysomnographs

            13.6.5. Peak Flow Meters

            13.6.6. Gas Analyzers

            13.6.7. Others

        13.7. Market Attractiveness, by Diagnostic & Monitoring Devices

        13.8. Market Value Forecast, by Application, 2017–2031

            13.8.1. Chronic Obstructive Pulmonary Disease

            13.8.2. Asthma

            13.8.3. Obstructive Sleep Apnea

            13.8.4. Respiratory Distress Syndrome

            13.8.5. Cystic Fibrosis

            13.8.6. Pneumonia

        13.9. Market Attractiveness, by Application

        13.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.10.1. China

            13.10.2. Japan

            13.10.3. India

            13.10.4. Australia & New Zealand

            13.10.5. Rest of Asia Pacific

        13.11. Market Attractiveness Analysis

            13.11.1. By Product Type

            13.11.2. By Therapeutic Devices

            13.11.3. By Diagnostic & Monitoring Devices

            13.11.4. By Application

            13.11.5. By Country/Sub-region

    14. Latin America Respiratory Devices Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product Type, 2017–2031

            14.2.1. Therapeutic Devices

            14.2.2. Diagnostic & Monitoring Devices

        14.3. Market Attractiveness, by Product Type

        14.4. Market Value Forecast, by Therapeutic Devices, 2017–2031

            14.4.1. Drug Delivery Devices

                14.4.1.1. Nebulizers

                14.4.1.2. Inhalers

            14.4.2. Mechanical Ventilators

                14.4.2.1. Invasive

                14.4.2.2. Non-invasive

            14.4.3. Continuous Positive Airway Pressure

                14.4.3.1. Devices

                14.4.3.2. Disposables

            14.4.4. Resuscitators

                14.4.4.1. Reusable

                14.4.4.2. Disposables

            14.4.5. Humidifiers

            14.4.6. Airway Clearance Devices

            14.4.7. Oxygen Concentrators

            14.4.8. Consumables & Disposables

            14.4.9. Others

        14.5. Market Attractiveness, by Therapeutic Devices

        14.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017–2031

            14.6.1. Pulse Oximeters

            14.6.2. Capnographs

            14.6.3. Spirometers

            14.6.4. Polysomnographs

            14.6.5. Peak Flow Meters

            14.6.6. Gas Analyzers

            14.6.7. Others

        14.7. Market Attractiveness, by Diagnostic & Monitoring Devices

        14.8. Market Value Forecast, by Application, 2017–2031

            14.8.1. Chronic Obstructive Pulmonary Disease

            14.8.2. Asthma

            14.8.3. Obstructive Sleep Apnea

            14.8.4. Respiratory Distress Syndrome

            14.8.5. Cystic Fibrosis

            14.8.6. Pneumonia

        14.9. Market Attractiveness, by Application

        14.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.10.1. Brazil

            14.10.2. Mexico

            14.10.3. Rest of Latin America

        14.11. Market Attractiveness Analysis

            14.11.1. By Product Type

            14.11.2. By Therapeutic Devices

            14.11.3. By Diagnostic & Monitoring Devices

            14.11.4. By Application

            14.11.5. By Country/Sub-region

    15. Middle East & Africa Respiratory Devices Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Product Type, 2017–2031

            15.2.1. Therapeutic Devices

            15.2.2. Diagnostic & Monitoring Devices

        15.3. Market Attractiveness, by Product Type

        15.4. Market Value Forecast, by Therapeutic Devices, 2017–2031

            15.4.1. Drug Delivery Devices

                15.4.1.1. Nebulizers

                15.4.1.2. Inhalers

            15.4.2. Mechanical Ventilators

                15.4.2.1. Invasive

                15.4.2.2. Non-invasive

            15.4.3. Continuous Positive Airway Pressure

                15.4.3.1. Devices

                15.4.3.2. Disposables

            15.4.4. Resuscitators

                15.4.4.1. Reusable

                15.4.4.2. Disposables

            15.4.5. Humidifiers

            15.4.6. Airway Clearance Devices

            15.4.7. Oxygen Concentrators

            15.4.8. Consumables & Disposables

            15.4.9. Others

        15.5. Market Attractiveness, by Therapeutic Devices

        15.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017–2031

            15.6.1. Pulse Oximeters

            15.6.2. Capnographs

            15.6.3. Spirometers

            15.6.4. Polysomnographs

            15.6.5. Peak Flow Meters

            15.6.6. Gas Analyzers

            15.6.7. Others

        15.7. Market Attractiveness, by Diagnostic & Monitoring Devices

        15.8. Market Value Forecast, by Application, 2017–2031

            15.8.1. Chronic Obstructive Pulmonary Disease

            15.8.2. Asthma

            15.8.3. Obstructive Sleep Apnea

            15.8.4. Respiratory Distress Syndrome

            15.8.5. Cystic Fibrosis

            15.8.6. Pneumonia

        15.9. Market Attractiveness, by Application

        15.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.10.1. GCC Countries

            15.10.2. South Africa

            15.10.3. Rest of Middle East & Africa

        15.11. Market Attractiveness Analysis

            15.11.1. By Product Type

            15.11.2. By Therapeutic Devices

            15.11.3. By Diagnostic & Monitoring Devices

            15.11.4. By Application

            15.11.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player - Competition Matrix (By Tier and Size of Companies)

        16.2. Market Share Analysis, by Company (2022)

        16.3. Company Profiles

            16.3.1. ResMed

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Product Portfolio

                16.3.1.3. Financial Overview

                16.3.1.4. SWOT Analysis

                16.3.1.5. Strategic Overview

            16.3.2. Koninklijke Philips N.V.

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Product Portfolio

                16.3.2.3. Financial Overview

                16.3.2.4. SWOT Analysis

                16.3.2.5. Strategic Overview

            16.3.3. Vyaire Medical

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Product Portfolio

                16.3.3.3. Financial Overview

                16.3.3.4. SWOT Analysis

                16.3.3.5. Strategic Overview

            16.3.4. Smiths Medical

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Product Portfolio

                16.3.4.3. Financial Overview

                16.3.4.4. SWOT Analysis

                16.3.4.5. Strategic Overview

            16.3.5. Fisher & Paykel Healthcare Limited

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Product Portfolio

                16.3.5.3. Financial Overview

                16.3.5.4. SWOT Analysis

                16.3.5.5. Strategic Overview

            16.3.6. Drägerwerk AG & Co.

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Product Portfolio

                16.3.6.3. Financial Overview

                16.3.6.4. SWOT Analysis

                16.3.6.5. Strategic Overview

            16.3.7. GE Healthcare

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Product Portfolio

                16.3.7.3. Financial Overview

                16.3.7.4. SWOT Analysis

                16.3.7.5. Strategic Overview

            16.3.8. Getinge AB

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Product Portfolio

                16.3.8.3. Financial Overview

                16.3.8.4. SWOT Analysis

                16.3.8.5. Strategic Overview

            16.3.9. Medtronic plc

                16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.9.2. Product Portfolio

                16.3.9.3. Financial Overview

                16.3.9.4. SWOT Analysis

                16.3.9.5. Strategic Overview

            16.3.10. Chart Industries

                16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.10.2. Product Portfolio

                16.3.10.3. Financial Overview

                16.3.10.4. SWOT Analysis

                16.3.10.5. Strategic Overview

    List of Tables

    Table 01: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 02: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

    Table 03: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 04: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017–2031

    Table 05: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 06: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 07: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 08: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

    Table 9: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017–2031

    Table 10: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 11: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 12: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 13: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

    Table 14: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017–2031

    Table 15: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 16: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 17: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 18: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

    Table 19: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017–2031

    Table 20: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 21: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 23: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

    Table 24: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017–2031

    Table 25: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 26: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 27: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 28: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

    Table 29: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017–2031

    Table 30: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017–2031

    List of Figures

    Figure 01: Global Respiratory Devices Market Size (US$ Mn), by Region, 2022 and 2031

    Figure 02: Global Respiratory Devices Market Revenue (US$ Mn), by Product Type, 2022

    Figure 03: Global Respiratory Devices Market Value Share, by Product Type, 2022

    Figure 04: Global Respiratory Devices Market Revenue (US$ Mn), by Therapeutic Devices, 2022

    Figure 05: Global Respiratory Devices Market Value Share, by Therapeutic Devices, 2022

    Figure 06: Global Respiratory Devices Market Revenue (US$ Mn), by Diagnostic & Monitoring Devices, 2022

    Figure 07: Global Respiratory Devices Market Value Share, by Diagnostic & Monitoring Devices, 2022

    Figure 08: Global Respiratory Devices Market Revenue (US$ Mn), by Application, 2022

    Figure 09: Global Respiratory Devices Market Value Share, by Application, 2022

    Figure 10: Global Respiratory Devices Market Value Share, by Region, 2022

    Figure 11: Global Respiratory Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 12: Global Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 13: Global Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 14: Global Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031

    Figure 15: Global Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023-2031

    Figure 16: Global Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031

    Figure 17: Global Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023-2031

    Figure 18: Global Respiratory Devices Market Revenue (US$ Mn), by Application, 2022

    Figure 19: Global Respiratory Devices Market Value Share, by Application, 2022

    Figure 20: Global Respiratory Devices Market Value Share Analysis, by Region, 2022 and 2031

    Figure 21: Global Respiratory Devices Market Attractiveness Analysis, by Region, 2023-2031

    Figure 22: North America Respiratory Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 23: North America Respiratory Devices Market Attractiveness Analysis, by Country, 2023–2031

    Figure 24: North America Respiratory Devices Market Value Share Analysis, by Country, 2022 and 2031

    Figure 25: North America Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 26: North America Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031

    Figure 27: North America Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031

    Figure 28: North America Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 29: North America Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 30: North America Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023–2031

    Figure 31: North America Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023–2031

    Figure 32: North America Respiratory Devices Market Attractiveness Analysis, by Application, 2023–2031

    Figure 33: Europe Respiratory Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 34: Europe Respiratory Devices Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 35: Europe Respiratory Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 36: Europe Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 37: Europe Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031

    Figure 38: Europe Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031

    Figure 39: Europe Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 40: Europe Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 41: Europe Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023–2031

    Figure 42: Europe Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023–2031

    Figure 43: Europe Respiratory Devices Market Attractiveness Analysis, by Application, 2023–2031

    Figure 44: Asia Pacific Respiratory Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 45: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 46: Asia Pacific Respiratory Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 47: Asia Pacific Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 48: Asia Pacific Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031

    Figure 49: Asia Pacific Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031

    Figure 50: Asia Pacific Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 51: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 52: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023–2031

    Figure 53: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023–2031

    Figure 54: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Application, 2022–2031

    Figure 55: Latin America Respiratory Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 56: Latin America Respiratory Devices Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 57: Latin America Respiratory Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 58: Latin America Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 59: Latin America Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031

    Figure 60: Latin America Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031

    Figure 61: Latin America Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 62: Latin America Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 63: Latin America Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023–2031

    Figure 64: Latin America Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023–2031

    Figure 65: Latin America Respiratory Devices Market Attractiveness Analysis, by Application, 2023–2031

    Figure 66: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 67: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 68: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 69: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 70: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031

    Figure 71: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031

    Figure 72: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 73: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 74: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023–2031

    Figure 75: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023–2031

    Figure 76: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Application, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved